Mydayis 54092-0474
Generic: Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, And Amphetamine Sulfate
Product NDC
54092-0474- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- June 20, 2017
- Listing Expires
- December 31, 2027
- Application
- NDA022063
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 9.375 mg/1 |
| Amphetamine Sulfate | 9.375 mg/1 |
| Dextroamphetamine Saccharate | 9.375 mg/1 |
| Dextroamphetamine Sulfate | 9.375 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Packaging Options(1)
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-474-01)